RNS - False Posting Called Out!14 Aug 2025 10:41
All this scaremongering was misleading and false..
The Company wishes to highlight that the apparent communication refers to services provided by NHS Genomic Services overseeing laboratory genomic testing and not point of care technologies. The funding position is being kept under active review as noted in the apparent communication.
Furthermore, whilst the Company is aware of the completion of the NHSE CYP2C19 pilot assessing logistics of deploying as a service at scale via laboratory or point of care, and what, based on interim assessment it anticipates to be a positive outcome supporting the role and impact of rapid CYP2C19 genetic testing in stroke patients, it has not yet been made aware of a publication date by NHSE and cannot confirm the dates reportedly conveyed in the communication.